The brain's energy system is a crucial, yet often overlooked, aspect of Alzheimer's research. For decades, the focus has been on the neuron, the brain's primary information processor, and its deterioration. However, this singular focus has led to the failure of numerous drug trials. The issue lies in the brain's energy system, which is responsible for sustaining the neuron's function. Astrocytes, the brain's master energy operators, play a vital role in this system. They extract glucose from cerebral blood vessels, convert it into lactate, and shuttle it directly into active neurons during periods of heightened cognitive demand. This lactate is not just fuel but also a signaling molecule that enhances the activity of NMDA receptors, which are essential for synaptic transmission, learning, and memory. When astrocytes are damaged or diseased, as occurs in Alzheimer's, they lose their capacity to produce and transport lactate efficiently, leading to the starvation and death of neurons. This reframing of the disease has significant implications for therapeutic strategy. Preserving the functional integrity of the neuron-astrocyte unit must become a central objective of dementia therapeutics. Targeted interventions that support astrocyte metabolism and protect the brain's energy infrastructure are necessary to prevent irreversible neuronal loss.
